Zomedica (ZOMDF) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Zomedica Corp   (NONE: ZOMDF)

Select the Financial Report: Select the Period:


Description of Zomedica's Business Segments
The company's reportable segments include Diagnostics, Therapeutic Devices, and Development Services. In the third quarter of 2025, Development Services was added as an additional segment. This addition did not alter the composition, product lines, or prior period amounts of the existing segments.

Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Composition of Zomedica Corp Revenues by Segments
 
Capital    23.27 % of total Revenue
Consumables    64.47 % of total Revenue
Engineering    14.66 % of total Revenue
Other    1.31 % of total Revenue
Diagnostics    11.39 % of total Revenue
Diagnostics Capital    1.97 % of total Revenue
Diagnostics Consumables    9.42 % of total Revenue
Therapeutic Devices    68.61 % of total Revenue
Therapeutic Devices Capital    16.89 % of total Revenue
Therapeutic Devices Consumables    51.5 % of total Revenue
Therapeutic Devices Other    0.22 % of total Revenue
Development Services    23.72 % of total Revenue
Development Services Capital    4.41 % of total Revenue
Development Services Consumables    3.56 % of total Revenue
Development Services Engineering    14.66 % of total Revenue
Development Services Other    1.08 % of total Revenue
US    87.02 % of total Revenue
Foreign countries    16.69 % of total Revenue

Q1 three months ended (Mar 31 2026)
Revenues by Business Segments Revenues
(in millions $)		 %
(of total Revenues)
Capital 1.97 23.27 %
Consumables 5.47 64.47 %
Engineering 1.24 14.66 %
Other 0.11 1.31 %
Diagnostics 0.97 11.39 %
Diagnostics Capital 0.17 1.97 %
Diagnostics Consumables 0.80 9.42 %
Therapeutic Devices 5.82 68.61 %
Therapeutic Devices Capital 1.43 16.89 %
Therapeutic Devices Consumables 4.37 51.5 %
Therapeutic Devices Other 0.02 0.22 %
Development Services 2.01 23.72 %
Development Services Capital 0.37 4.41 %
Development Services Consumables 0.30 3.56 %
Development Services Engineering 1.24 14.66 %
Development Services Other 0.09 1.08 %
US 7.38 87.02 %
Foreign countries 1.42 16.69 %
Total 8.48 100 %




Q1 three months ended (Mar 31 2026)
Revenue Growth rates by Segment Y/Y Revenue
%		 Q/Q Revenue
%
Capital 0.92 % -
Consumables 21.64 % -
Engineering - -
Other 136.17 % -
Diagnostics 72.81 % -
Diagnostics Capital 7.05 % -
Diagnostics Consumables 98.26 % -
Therapeutic Devices -2.02 % -
Therapeutic Devices Capital -20.39 % -
Therapeutic Devices Consumables 6.72 % -
Therapeutic Devices Other -59.57 % -
Development Services - -
Development Services Capital - -
Development Services Consumables - -
Development Services Engineering - -
Development Services Other - -
US 46.11 % -
Foreign countries -2.14 % -
Total 32.42 % -73.22 %




Q1 three months ended (Mar 31 2026)
Income by Business Segments Income
(in millions $)		 %
(Profit Margin)
Diagnostics 0.35 36.34 %
Therapeutic Devices 4.05 69.54 %
Development Services 1.09 53.93 %
Total -4.53 -




Q1 three months ended (Mar 31 2026)
Income Growth rates by Segment Y/Y Income
%		 Q/Q Income
%
Diagnostics 17450 % -
Therapeutic Devices -8.1 % -
Development Services - -
Total - -




Annual Report on Zomedica Corp Divisions, Sales by Country

 
Capital   Capital Segment contribution to total sales 29.21 % of total Revenue
Consumables   Consumables Segment contribution to total sales 65.27 % of total Revenue
Engineering   Engineering Segment contribution to total sales 6.24 % of total Revenue
Other   Other Segment contribution to total sales 0.39 % of total Revenue
Diagnostics   Diagnostics Segment contribution to total sales 8.84 % of total Revenue
Diagnostics Capital   Diagnostics Capital Segment contribution to total sales 2.17 % of total Revenue
Diagnostics Consumables   Diagnostics Consumables Segment contribution to total sales 6.67 % of total Revenue
Therapeutic Devices   Therapeutic Devices Segment contribution to total sales 82.7 % of total Revenue
Therapeutic Devices Capital   Therapeutic Devices Capital Segment contribution to total sales 25.98 % of total Revenue
Therapeutic Devices Consumables   Therapeutic Devices Consumables Segment contribution to total sales 56.32 % of total Revenue
Therapeutic Devices Other   Therapeutic Devices Other Segment contribution to total sales 0.39 % of total Revenue
Development Services   Development Services Segment contribution to total sales 9.57 % of total Revenue
Development Services Capital   Development Services Capital Segment contribution to total sales 1.06 % of total Revenue
Development Services Consumables   Development Services Consumables Segment contribution to total sales 2.28 % of total Revenue
Development Services Engineering   Development Services Engineering Segment contribution to total sales 6.24 % of total Revenue
US   US Segment contribution to total sales 83.53 % of total Revenue
Foreign countries   Foreign countries Segment contribution to total sales 17.58 % of total Revenue


Twelve months ended 2025
ZOMDF s Annual Revenue by Geography and Business Segments Sales
(in millions $)		 %
(of total Sales)
Capital 9.25 29.21 %
Consumables 20.68 65.27 %
Engineering 1.98 6.24 %
Other 0.12 0.39 %
Diagnostics 2.80 8.84 %
Diagnostics Capital 0.69 2.17 %
Diagnostics Consumables 2.11 6.67 %
Therapeutic Devices 26.20 82.7 %
Therapeutic Devices Capital 8.23 25.98 %
Therapeutic Devices Consumables 17.84 56.32 %
Therapeutic Devices Other 0.12 0.39 %
Development Services 3.03 9.57 %
Development Services Capital 0.34 1.06 %
Development Services Consumables 0.72 2.28 %
Development Services Engineering 1.98 6.24 %
US 26.46 83.53 %
Foreign countries 5.57 17.58 %
Total 31.68 100 %


Twelve months ended 2025
ZOMDF s Annual Income by Country and Business Segments Income
(in millions $)		 %
(Profit Margin)
Diagnostics 0.30 10.53 %
Therapeutic Devices 19.32 73.76 %
Development Services 2.06 67.94 %
Total -81.86 -

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Capital -2.51 % -
Consumables 17.07 % -
Other -6.11 % -
Diagnostics 15.13 % 30.53 %
Diagnostics Capital -39.58 % -
Diagnostics Consumables 63.12 % -
Therapeutic Devices 5.41 % 2.45 %
Therapeutic Devices Capital -1.47 % -
Therapeutic Devices Consumables 9.02 % -
Therapeutic Devices Other -6.11 % -
US 17.31 % -
Foreign countries 17.76 % -
Total 16.95 % -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.